INHIBITION OF LYSOPHOSPHATIDATE-INDUCED AND THROMBIN-INDUCED NEURITE RETRACTION AND NEURONAL CELL ROUNDING BY ADP-RIBOSYLATION OF THE SMALLGTP-BINDING PROTEIN-RHO
K. Jalink et al., INHIBITION OF LYSOPHOSPHATIDATE-INDUCED AND THROMBIN-INDUCED NEURITE RETRACTION AND NEURONAL CELL ROUNDING BY ADP-RIBOSYLATION OF THE SMALLGTP-BINDING PROTEIN-RHO, The Journal of cell biology, 126(3), 1994, pp. 801-810
Addition of the bioactive phospholipid lysophosphatidic acid (LPA) or
a thrombin receptor-activating peptide (TRP) to serum-starved N1E-115
or NG108-15 neuronal cells causes rapid growth cone collapse, neurite
retraction, and transient rounding of the cell body. These shape chang
es appear to be driven by receptor-mediated contraction of the cortica
l actomyosin system independent of classic second messengers. Treatmen
t of the cells with Clostridium botulinum C3 exoenzyme, which ADP-ribo
sylates and thereby inactivates the Rho small GTP-binding protein, inh
ibits LPA- and TRP-induced force generation and subsequent shape chang
es. C3 also inhibits LPA-induced neurite retraction in PC12 cells. Bio
chemical analysis reveals that the ADP-ribosylated substrate is RhoA.
Prolonged C3 treatment of cells maintained in 10% serum induces the ph
enotype of serum-starved cells, with initial cell flattening being fol
lowed by neurite outgrowth; such C3-differentiated cells fail to retra
ct their neurites in response to agonists. We conclude that RhoA is es
sential for receptor-mediated force generation and ensuing neurite ret
raction in N1E115 and PC12 cells, and that inactivation of RhoA by ADP
-ribosylation abolishes actomyosin contractility and promotes neurite
outgrowth.